Philadelphia might be the most underrated golf city in America. Hear us out. 👇

Ever wonder how you teach an LLM to think like an oncologist? I wrote about the exciting work we're doing at @flatironhealth to extract clinical data from the EHR, thoroughly evaluate model performance, and advance research to benefit patients with cancer. Check it out!

Excited for our LLM work to come out in @AI_PrecisionOnc ! We used high quality labeled data to fine-tune LLMs and improve our ability to extract PD-L1 testing details across 10 different cancers! Reach out or click the link below to learn more about @flatironhealth work in #AI

After learning about @DavidFajgenbaum's unique journey with Castleman disease, Flatiron engineers used ML to better leverage Flatiron data, unlocking insights for a rare patient population. Read our #LearnTeachGrow article for a behind the scenes look: linkedin.com/pulse/using-mac…

I loved having the opportunity to learn more about our impressive grantees and the impactful research they are pursuing to help improve equity in cancer care.

@flatironhealth & @AmericanCancer's Real-World Data Impact Award offers a unique opportunity to drive research answering key questions for patients w/ cancer ⏯️Watch now for a live roundtable with this year’s grantees, moderated by @aaronbcohen page.flatiron.com/2023-real-…

So appreciative of @MoffittNews for having me at their annual Business of Biotech conference to speak about the opportunities and challenges of #artificialintelligence in cancer care and research. And thanks to my fellow panelists for a great discussion. @flatironhealth

So great to be at the @ASH_hematology annual meeting where we’re holding our annual @CureCastleman workshop and our team is giving 6 presentations (below). cdcn.org/physicians-research… Let us know if you’re in #sandiego and want to meet up! Identification of Autoantibodies Associated with Connective Tissue Disorders in Idiopathic Multicentric Castleman Disease ash.confex.com/ash/2023/webp… Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort ash.confex.com/ash/2023/webp… Clinical Characteristics and Treatment Outcomes of Idiopathic Multicentric Castleman Disease: Data from a Pediatric Cohort ash.confex.com/ash/2023/webp… Exploratory Analyses of Lymph Node Tissue, Serum, and Peripheral Blood Mononuclear Cells Do Not Reveal Pathogen Signatures in Idiopathic Multicentric Castleman Disease ash.confex.com/ash/2023/webp… A Translational Approach to Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman Disease ash.confex.com/ash/2023/webp… The Role of CABIN1 in the Pathogenesis of Idiopathic Multicentric Castleman Disease ash.confex.com/ash/2023/webp… #castlemanwarrior #castleman

Our presence at #ASCO23 showcases how #RWD allows us to enhance representativeness of trials, generate insights into diverse patient populations, & unlock opportunities to improve #healthequity. Learn more about our team’s presence at this year’s @ASCO ➡️events.flatiron.com/asco-202…

Now out in Applied Sciences, our team @flatironhealth built a high performing NLP algorithm to improve completeness of ECOG performance status across 21 different cancer types. Proud of the team, the work, and the impact it has. mdpi.com/2076-3417/13/10/620…